CNTX
Context Therapeutics Inc. Common Stock
Echtzeitkurs
Kursdiagramm
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$0.620
Hoch
$0.620
Tief
$0.620
Volumen
0.18M
Unternehmensfundamentaldaten
Handelsstatistiken
Ähnliche Nachrichten
Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting
Dosing cohort 3 of Phase 1 trial of CTIM-76, a Claudin 6 x CD3 T cell engager Expect to share initial data in the first half of 2026 PHILADELPHIA, June 02, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc.
Context Therapeutics to Appoint Dr. Karen Chagin, M.D. as Chief Medical Officer
PHILADELPHIA, May 29, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. ("Context" or "Company") (NASDAQ:CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid
Ähnliche Aktien
ADMA
ADMA Biologics Inc
CUBA
Herzfeld Caribbean Basin Fund Inc. (The)
KZR
Kezar Life Sciences Inc.
ECAT
BlackRock ESG Capital Allocation Term Trust Common Shares of Beneficial Interest
AVO
Mission Produce Inc.
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.